Eph receptor signalling casts a wide net on cell behaviour

Nature Reviews Molecular Cell Biology

Volumn 6, Issue 6, 2005, Pages 462-475

  Pasquale, Elena B ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN RECEPTOR; LIGAND; PROTEIN TYROSINE KINASE;

CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; DENDRITIC SPINE; HOMEOSTASIS; MEMBRANE BINDING; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR DENSITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOVEMENT; CELL PHYSIOLOGY; CELL PROLIFERATION; EPHRINS; HUMANS; NEURONS; PROTEIN BINDING; RECEPTOR, EPHA1; SIGNAL TRANSDUCTION;

EID: 20344396123     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1662     Document Type: Review

References (132)

1. Murai, K. K. & Pasquale, E. B. 'Eph' ective signaling: forward, reverse and crosstalk. J. Cell Sci. 116, 2823-2832 (2003).
2. Pasquale, E. B. Eph-ephrin promiscuity is now crystal clear. Nature Neurosci. 7, 417-418 (2004).
3. Zisch, A. H. & Pasquale, E. B. The Eph family: a multitude of receptors that mediate cell recognition signals. Cell Tissue Res. 290, 217-226 (1997).
4. Himanen, J. P. et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nature Neurosci. 7, 501-509 (2004).
5. Flanagan, J. G. & Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21, 309-345 (1998).
6. Wilkinson, D. G. Multiple roles of Eph receptors and ephrins in neural development. Nature Rev. Neurosci. 2, 155-164 (2001).
7. Kullander, K. & Klein, R. Mechanisms and functions of Eph and ephrin signalling. Nature Rev. Mol. Cell Biol. 3, 475-486 (2002).
8. Himanen, J. P. & Nikolov, D. B. Eph signaling: a structural view. Trends Neurosci. 26, 46-51 (2003).
9. Himanen, J. P. et al. Crystal structure of an Eph receptor-ephrin complex. Nature 414, 933-938 (2001). Identifies two binding interfaces between EphB2 and ephrin-B2 and determines their high resolution structure. On the basis of the structural findings, it proposes that Eph-receptor-ephrin signalling complexes form tetramers that can further assemble into larger signalling clusters.
10. Toth, J. et al. Crystal structure of an ephrin ectodomain. Dev. Cell 1, 83-92 (2001).
11. Smith, F. M. et al. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J. Biol. Chem. 279, 9522-9531 (2004).
12. Wimmer-Kleikamp, S. H., Janes, P. W., Squire, A., Bastiaens, P. I. & Lackmann, M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 164, 661-666 (2004).
13. Kalo, M. S. & Pasquale, E. B. Signal transfer by Eph receptors. Cell Tissue Res. 298, 1-9 (1999).
14. Knoll, B. & Drescher, U. Src family kinases are involved in EphA receptor-mediated retinal axon guidance. J. Neurosci. 24, 6248-6257 (2004).
15. Zisch, A. H. et al. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses. Oncogene 19, 177-187 (2000).
16. Wybenga-Groot, L. E. et al. Structural basis for autoinhibition of the EphB2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106, 745-757 (2001).
17. Palmer, A. et al. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol. Cell 9, 725-737 (2002).
18. Song, J. Tyrosine phosphorylation of the well packed ephrinB cytoplasmic β-hairpin for reverse signaling. Structural consequences and binding properties. J. Biol. Chem. 278, 24714-24720 (2003).
19. Brantley-Sieders, D., Parker, M. & Chen, J. Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr. Pharm. Des. 10, 3431-3442 (2004).
20. Prevost, N., Woulfe, D., Tognolini, M. & Brass, L. F. Contact-dependent signaling during the late events of platelet activation. J. Thromb. Haemost. 1, 1613-1627 (2003).
21. Noren, N. K. & Pasquale, E. B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal. 16, 655-666 (2004).
22. Kikawa, K. D., Vidale, D. R., Van Etten, R. L. & Kinch, M. S. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J. Biol. Chem. 277, 39274-39279 (2002).
23. Walker-Daniels, J., Riese, D. J. II & Kinch, M. S. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol. Cancer Res. 1, 79-87 (2002).
24. Wang, Y. et al. Negative regulation of EphA2 receptor by Cbl. Biochem. Biophys. Res. Commun. 296, 214-220 (2002).
25. Freywald, A., Sharfe, N. & Roifman, C. M. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J. Biol. Chem. 277, 3823-3828 (2002).
26. Gu, C. & Park, S. The EphA8 receptor regulates integrin activity through p110γ phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol. Cell. Biol. 21, 4579-4597 (2001).
27. Miao, H. et al. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase: role of Rho family small GTPases. J. Biol. Chem. 280, 923-932 (2005).
28. Yin, Y. et al. EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci. Res. 48, 285-296 (2004).
29. Wu, C., Butz, S., Ying, Y. & Anderson, R. G. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem. 272, 3554-3559 (1997).
30. Bruckner, K. et al. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22, 511-524 (1999).
31. Huai, J. & Drescher, U. An ephrin-A-dependent signaling pathway controls integrin function and is linked to the tyrosine phosphorylation of a 120-kDa protein. J. Biol. Chem. 276, 6689-6694 (2001).
32. Gauthier, L. R. & Robbins, S. M. Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them? Life Sci. 74, 207-216 (2003).
33. Knoll, B. & Drescher, U. Ephrin-As as receptors in topographic projections. Trends Neurosci. 25, 145-149 (2002).
34. Holmberg, J., Clarke, D. L. & Frisen, J. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408, 203-206 (2000).
35. Dravis, C. et al. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev. Biol. 271, 272-290 (2004).
36. Santiago, A. & Erickson, C. A. Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 129, 3621-3632 (2002).
37. Hindges, R., McLaughlin, T., Genoud, N., Henkemeyer, M. & O'Leary, D. EphB forward signaling controls directional branch extension and arborization required for dorsal-ventral retinotopic mapping. Neuron 35, 475-487 (2002).
38. McLaughlin, T., Hindges, R., Yates, P. A. & O'Leary, D. D. Bifunctional action of ephrin-B1 as a repellent and attractant to control bidirectional branch extension in dorsal-ventral retinotopjc mapping. Development 130, 2407-2418 (2003).
39. Eberhart, J. et al. Ephrin-A5 exerts positive or inhibitory effects on distinct subsets of EphA4-positive motor neurons. J. Neurosci. 24, 1070-1078 (2004).
40. Weinl, C., Drescher, U., Lang, S., Bonhoeffer, F. & Loschinger, J. On the turning of Xeoopus retinal axons induced by ephrin-A5. Development 130, 1635-1643 (2003).
41. Davenport, R. W., Thies, E. & Cohen, M. L. Neuronal growth cone collapse triggers lateral extensions along trailing axons. Mature Neurosci. 2, 254-259 (1999).
42. Castellani, V., Yue, Y., Gao, P. P., Zhou, R. & Bolz, J. Dual action of a ligand for Eph receptor tyrosine kinases on specific populations of axons during the development of cortical circuits. J. Neurosci. 18, 4663-4672 (1998).
43. Yates, P. A., Roskies, A. L., McLaughlin, T. & O'Leary, D. D. Topographic-specific axon branching controlled by ephrin-As is the critical event in retinotectal map development. J. Neurosci. 21, 8548-8563 (2001). Provides evidence that an important effect of ephrin-A ligands in the regulation of topographic synaptic connections in the visual system involves inhibition of collateral branching rather than only growth cone repulsion, as was previously believed.
44. Sakurai, T., Wong, E., Drescher, U., Tanaka, H. & Jay, D. G. Ephrin-A5 restricts topographically specific arborization in the chick retinotectal projection in vivo. Proc. Natl Acad. USA 99, 10795-10800 (2002).
45. Hansen, M. J., Dallal, G. E. & Flanagan, J. G. Retinal axon response to ephrin-As shows a graded, concentration-dependent transition from growth promotion to inhibition. Neuron 42, 717-730 (2004). Shows that ephrin-A ligands can promote retinal axon outgrowth when present on the substrate at low density, in contrast to the inhibitory effects of these ligands when they are at high density. The concentration of EphA receptors on the axons also influences axon growth promotion versus inhibition.
46. Hattori, M., Osterfield, M. & Flanagan, J. G. Regulated cleavage of a contact-mediated axon repellent. Science 289, 1360-1365 (2000). Identifies ephrin-A proteolysis as a mechanism to allow cell separation following formation of transcellular Eph-ephrin adhesive complexes.
47. Zimmer, M., Palmer, A., Kohler, J. & Klein, R. EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nature Cell Biol. 5, 869-878 (2003).
48. Mann, F., Miranda, E., Weinl, C., Harmer, E. & Holt, C. E. B-type Eph receptors and ephrins induce growth cone collapse through distinct intracellular pathways. J. Neurobiol. 57, 323-336 (2003).
49. Marston, D. J., Dickinson, S. & Nobes, C. D. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nature Cell Biol. 5, 879-888 (2003). References 47 and 49 identify endocytosis as a mechanism to remove intact Eph-receptor-ephrin adhesive complexes from sites of cell contact, thereby facilitating cell separation.
50. Pascall, J. C. & Brown, K. D. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem. Biophys. Res. Commun. 317, 244-252 (2004).
51. Stein, E. et al. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12, 667-678 (1998). First article to propose that the degree of Eph receptor clustering can change cellular responses to Eph signalling.
52. Mann, F., Ray, S., Harris, W. & Holt, C. Topographic mapping in dorsoventral axis of the Xenopus retinotectal system depends on signaling through Ephrin-B ligands. Neuron 35, 461-473 (2002).
53. Nagashima, K. et al. Adaptor protein Crk is required for Ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol. Biol. Cell 13, 4231-4242 (2002).
54. 1 integrins. EMBO J. 18, 2165-2173 (1999).
55. Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M. & Pasquale, E. B. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc. Natl Acad. Sci. USA 101, 5583-5588 (2004).
56. Fuller, T., Korff, T., Kilian, A., Dandekar, G. & Augustin, H. G. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J. Cell Sci. 116, 2461-2470 (2003).
57. Prevost, N., Woulfe, D., Tanaka, T. & Brass, L. F. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc. Natl Acad. Sci. USA 99, 9219-9224 (2002).
58. Suh, L. H., Oster, S. F., Soehrman, S. S., Grenningloh, G. & Sretavan, D. W. L1/Laminin modulation of growth cone response to EphB triggers growth pauses and regulates the microtubule destabilizing protein SCG10. J. Neurosci. 24, 1976-1986 (2004).
59. Dufour, A. et al. Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. Neuron 39, 453-465 (2003).
60. Frisen, J., Holmberg, J. & Barbacid, M. Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J. 18, 5159-5165 (1999).
61. Drescher, U. et al. In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82, 359-370 (1995). Identifies ephrin-A5 as the long sought-after repellent for retinal axons by biochemical purification from posterior chicken tectum.
62. Brown, A. et al. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 102, 77-88 (2000).
63. Reber, M., Burrola, P. & Lemke, G. A relative signalling model for the formation of a topographic neural map. Nature 431, 847-853 (2004).
64. Honda, H. Competition between retinal ganglion axons for targets under the servomechanism model explains abnormal retinocollicular projection of Eph receptor-overexpressing or ephrin-lacking mice. J. Neurosci. 23, 10368-10377 (2003).
65. Koulakov, A. A. & Tsigankov, D. N. A stochastic model for retinocollicular map development. BMC Neurosci. 5, 30-47 (2004).
66. Yates, P. A., Holub, A. D., McLaughlin, T., Sejnowski, T. J. & O'Leary, D. D. Computational modeling of retinotopic map development to define contributions of EphA-ephrinA gradients, axon-axon interactions, and patterned activity. J. Neurobiol. 59, 95-113 (2004).
67. Feldheim, D. A. et al. Loss-of-function analysis of EphA receptors in retinotectal mapping. J. Neurosci. 24, 2542-2550 (2004).
68. Feldheim, D. A. et al. Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 25, 563-574 (2000).
69. Frisen, J. et al. Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system. Neuron 20, 235-243 (1998).
70. Birgbauer, E., Cowan, C. A., Sretavan, D. W. & Henkemeyer, M. Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development 127, 1231-1241 (2000).
71. Williams, S. E. et al. Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron 39, 919-935 (2003).
72. Nakagawa, S. et al. Ephrin-B regulates the ipsilateral routing of retinal axons at the optic chiasm. Neuron 25, 599-610 (2000).
73. McLaughlin, T., Hindges, R., Yates, P. A. & O'Leary, D. D. Bifunctional action of ephrin-B1 as a repellent and attractant to control bidirectional branch extension in dorsal-ventral retinotopic mapping. Development 130, 2407-2418 (2003).
74. Winslow, J. W. et al. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 14, 973-981 (1995).
75. Chen, Z. Y. et al. Abnormal hippocampal axon bundling in EphB receptor mutant mice. J. Neurosci. 24, 2366-2374 (2004).
76. Murai, K. K. & Pasquale, E. B. Eph receptors, ephrins, and synaptic function. Neuroscientist 10, 304-314 (2004).
77. Yamaguchi, Y. & Pasquale, E. B. Eph receptors in the adult brain. Curr. Opin. Neurobiol. 14, 288-296 (2004).
78. Ethell, I. M. et al. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31, 1001-1013 (2001).
79. Henkemeyer, M., Itkis, O. S., Ngo, M., Hickmott, P. W. & Ethell, I. M. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. J. Cell Biol. 163, 1313-1326 (2003).
80. Penzes, P. et al. Rapid induction of dendritic spine morphogenesis by trans-synaptic EphrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 37, 263-274 (2003).
81. Dalva, M. B. et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103, 945-956 (2000).
82. Murai, K. K., Nguyen, L. N., Irie, F., Yamaguchi, Y. & Pasquale, E. B. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nature Neurosci. 6, 153-160 (2003). Identifies a form of neuroglial crosstalk that regulates dendritic spine shape through repulsive signalling by an EphA receptor on hippocampal pyramidal neurons and an ephrin-A ligand on glial cells.
83. Zhou, F. Q. & Cohan, C. S. How actin filaments and microtubules steer growth cones to their targets. J. Neurobiol. 58, 84-91 (2004).
84. Gu, J., Sumida, Y., Sanzen, N. & Sekiguchi, K. Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-Crkll-DOCK180 pathway. J. Biol. Chem. 276, 27090-27097 (2001).
85. Thies, E. & Davenport, R. W. Independent roles of Rho-GTPases in growth cone and axonal behavior. J. Neurobiol. 54, 358-369 (2003).
86. Birchmeier, C., Birchmeler, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol. 4, 915-925 (2003).
87. Miao, H. et al. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J. Cell Biol. 162, 1281-1292 (2003).
88. Stein, E., Schoecklmann, H. & Daniel, T. O. Eph family receptors and ligands in vascular cell targeting and assembly. Trends Cardiovasc. Med. 7, 329-334 (1997).
89. Wang, H. U., Chen, Z. F. & Anderson, D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753 (1998). Identifies ephrin-B2 as a marker for embryonic arterial endothelial cells and, together with reference 90, reveals the essential role in cardiovascular development of this ephrin and the EphB4 receptor in venous endothelial cells.
90. Gerety, S. S., Wang, H. U., Chen, Z. F. & Anderson, D. J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4, 403-414 (1999).
91. Adams, R. H. et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295-306 (1999).
92. Makinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397-410 (2005). Reports an essential role for ephrin-B2 in the formation of the lymphatic vasculature and begins to identify the reverse signalling pathways involved using genetic approches.
93. Pandey, A., Shao, H., Marks, R. M., Polverini, P. J. & Dixit, V. M. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-α-induced angiogenesis. Science 268, 567-569 (1995). First demonstration that an Eph receptor, EphA2, has a role in pathological angiogenesis in the adult.
94. Brantley, D. M. et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21, 7011-7026 (2002).
95. Dobrzanski, P. et al. Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 64, 910-919 (2004).
96. Brantley-Sieders, D. M. et al. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 117, 2037-2049 (2004).
97. Cowan, C. A. et al. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev. Biol. 271, 263-271 (2004).
98. Compagni, A., Logan, M., Klein, R. & Adams, R. H. Control of skeletal patterning by ephrinB1-EphB interactions. Dev. Cell 5, 217-230 (2003). This article and reference 99 demonstrate the crucial role of ephrin-B1 in embryonic patterning by the formation of tissue boundaries.
99. Davy, A., Aubin, J. & Soriano, P. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18, 572-583 (2004).
100. Twigg, S. R. et al. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc. Natl Acad. Sci. USA 101, 8652-8657 (2004). This article and reference 101 implicate ephrin-B1 mutations in a human genetic disease, craniofrontonasal syndrome. The disease phenotype is probably the result of abnormalities in the formation of embryonic tissue boundaries (see also references 98 and 99).
101. Wieland, I. et al. Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am. J. Hum. Genet. 74, 1209-1215 (2004).
102. Batlle, E. et al. β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111, 251-263 (2002).
103. Sharfe, N., Freywald, A., Toro, A., Dadi, H. & Roifman, C. Ephrin stimulation modulates T cell chemotaxis. Eur. J. Immunol. 32, 3745-3755 (2002).
104. Lu, Q., Sun, E. E., Klein, R. S. & Flanagan, J. G. Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105, 69-79 (2001).
105. Huynh-Do, U. et al. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 115, 3073-3081 (2002).
106. Vindis, C., Cerretti, D. P., Daniel, T. O. & Huynh-Do, U. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J. Cell Biol. 162, 661-671 (2003).
107. Vindis, C., Teli, T., Cerretti, D. P., Turner, C. E. & Huynh-Do, U. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. J. Biol. Chem. 279, 27965-27970 (2004).
108. Lickliter, J. D., Smith, F. M., Olsson, J. E., Mackwell, K. L. & Boyd, A. W. Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. Proc. Natl Acad. Sci. USA 93, 145-150 (1996).
109. Tumbar, T. et al. Defining the epithelial stem cell niche in skin. Science 303, 359-363 (2004).
110. Aoki, M., Yamashita, T. & Tohyama, M. EphA receptors direct the differentiation of mammalian neural precursor cells through a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 279, 32643-32650 (2004).
111. Suenobu, S. et al. A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis. Biochem. Biophys. Res. Commun. 293, 1124-1131 (2002).
112. Wang, Z. et al. Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells. Blood 99, 2740-2747 (2002).
113. Wang, Z. et al. Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels. Blood 103, 100-109 (2004).
114. Conover, J. C. et al. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nature Neurosci. 3, 1091-1097 (2000).
115. Holmberg, J. et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 19, 462-471 (2005).
116. Moore, K. B., Mood, K., Daar, I. O. & Moody, S. A. Morphogenetic movements underlying eye field formation require interactions between the FGF and ephrinB1 signaling pathways. Dev. Cell 6, 55-67 (2004).
117. Xu, Q., Alldus, G., Macdonald, R., Wilkinson, D. G. & Holder, N. Function of the Eph-related kinase rtk1 in patterning of the zebrafish forebrain. Nature 381, 319-322 (1996).
118. Barrios, A. et al. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis. Curr. Biol. 13, 1571-1582 (2003).
119. Rosenberg, I. M., Goke, M., Kanai, M., Reinecker, H. C. & Podolsky, D. K. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am. J. Physiol. 273, G824-G832 (1997).
120. Huusko, P. et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genet. 36, 979-983 (2004).
121. Sulman, E. P. et al. ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers. Genomics 40, 371-374 (1997).
122. Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).
123. Noblitt, L. W. et al. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. Cancer Gene Ther. 11, 757-766 (2004).
124. Henkemeyer, M. et al. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86, 35-46 (1996).
125. Holland, S. J. et al. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383, 722-725 (1996).
126. Bruckner, K., Pasquale, E. B. & Klein, R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275, 1640-1643 (1997).
127. Carles-Kinch, K., Kilpatrick, K. E., Stewart, J. C. & Kinch, M. S. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res. 62, 2840-2847 (2002).
128. Koolpe, M., Burgess, R., Dail, M. & Pasquale, E. B. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J. Biol. Chem. 280, 17301-17311 (2005).
129. Koolpe, M., Dail, M. & Pasquale, E. B. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J. Biol. Chem. 277, 46974-46979 (2002).
130. Mao, W. et al. EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer. Cancer Res. 64, 781-788 (2004).
131. Goldshmit, Y., Galea, M. P., Wise, G., Bartlett, P. F. & Turnley, A. M. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J. Neurosci. 24, 10064-10073 (2004). Proposes that EphA4 receptor signalling contributes to the failure of axon regeneration after spinal cord injury mainly by mediating the formation of a glial scar.
132. Marquardt, T. et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121, 127-139 (2005). Shows that EphA receptors and ephrin-A ligands expressed on the same growth cone segregate laterally into distinct membrane subdomains and both contribute to axon guidance: the EphA receptors by mediating repulsive effects, and the ephrin-A molecules by mediating attractive effects.